Jyong Biotech Ltd.
MENS
$55.24
$1.182.18%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 338.50K | 338.50K | 226.00K | 226.00K | 577.50K |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 552.50K | 552.50K | 475.50K | 475.50K | 844.00K |
| Operating Income | -552.50K | -552.50K | -475.50K | -475.50K | -844.00K |
| Income Before Tax | -846.50K | -846.50K | -663.00K | -663.00K | -1.33M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -846.50K | -846.50K | -663.00K | -663.00K | -1.33M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -846.50K | -846.50K | -663.00K | -663.00K | -1.33M |
| EBIT | -552.50K | -552.50K | -475.50K | -475.50K | -844.00K |
| EBITDA | -523.50K | -523.50K | -444.50K | -444.50K | -813.00K |
| EPS Basic | -0.01 | -0.01 | -0.01 | -0.01 | -0.02 |
| Normalized Basic EPS | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 |
| EPS Diluted | -0.01 | -0.01 | -0.01 | -0.01 | -0.02 |
| Normalized Diluted EPS | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 |
| Average Basic Shares Outstanding | 71.57M | 71.57M | 71.57M | 71.57M | 71.57M |
| Average Diluted Shares Outstanding | 71.57M | 71.57M | 71.57M | 71.57M | 71.57M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |